Sign in Pull a receipt

GRI

GRI Bio, Inc.

Healthcare · Biotechnology

$296.85 sample

+5.39 (+1.85%) 1D

Market cap

$1.07T

Price as of

2026-10-29

Latest filing

8-K · 2026-09-15

Alerts

8

Price$296.85 +6.86% 3M daily closessample

299.15273.73

2026-08-032026-08-252026-09-162026-10-072026-10-29

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 23INSInsider buy: Chief Executive Officer
Oct 19INSInsider sell: Director
Oct 14INSInsider buy: Director
Oct 06INSInsider buy: General Counsel
Oct 01INSInsider buy: EVP, Operations
Sep 24INSInsider buy: 10% owner
Sep 18INSInsider sell: 10% owner
Sep 15SEC10-Q filed

Sign up to see the real GRI record →

Company facts

SEC EDGAR registration

Name: GRI Bio, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +54sample, -100 to +100
Reporting currency: USD

Who is positioning in GRI

sample

Insiders: 18 insider transactions over 90 days, net selling, $706.2M
Congress: 1 members traded over 90 days
Institutions · 13F: 35 funds hold $12.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$25.3B +9.7% y/y

Q4 2024Q3 2026

Inventory$16.1B +18.5% y/y

Q4 2024Q3 2026

Accounts receivable$11.7B +6.5% y/y

Q4 2024Q3 2026

Total debt$30.1B +3.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $536.7B -10.3% 3M
Sample peer B: $960.5B +2.6% 3M
Sample peer C: $503.0B +5.9% 3M
Sample peer D: $859.5B +8.8% 3M
Sample peer E: $436.8B +11.5% 3M